SynthesisEye (London, England)2021

Efficacy and safety of the mineralocorticoid receptor antagonist treatment for central serous chorioretinopathy: a systematic review and meta-analysis.

Jianan Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.